Mads Nybo1, Anne-Mette Hvas2. 1. a Department of Clinical Biochemistry and Pharmacology , Odense University Hospital , Odense , Denmark. 2. b Department of Clinical Biochemistry , Aarhus University Hospital , Aarhus , Denmark.
Abstract
BACKGROUND: Studies have indicated that use of an age-adjusted D-dimer cut-off value for patients above 50 years increases utility of the diagnostic strategy for pulmonary embolism. Evidence for the same approach regarding diagnosis of deep vein thrombosis (DVT) is, however, unclear. MATERIALS AND METHODS: A systematic literature review was conducted following the PRISMA Statement guideline to gather the existing knowledge on the use of an age-adjusted D-dimer cut-off in the diagnostic strategy for DVT. Studies were extracted from Medline and the Cochrane Library. The search period ended in November 2016. RESULTS: Out of 73 articles retrieved, only eight studies addressed DVT either specifically or along with PE. None of these were randomized controlled trials, but were either prospective studies of consecutive outpatients or retrospective studies. Despite differences in study design, DVT prevalence, and D-dimer assay used, all studies were in favour of the age-adjusted D-dimer cut-off with negative predictive values (NPV) ranging from 91.8-100% compared to 89.7-100% for the standard D-dimer cut-off. All the studies concluded that use of an age-adjusted D-dimer cut-off resulted in an improved utility, although the results due to heterogeneity in reporting did not allow a direct comparison. CONCLUSION: Use of an age-adjusted D-dimer cut-off for patients above 50 years of age for ruling out DVT seems as safe as using a standard D-dimer cut-off. The recommended (and most used) adjustment is by the formula (patient's age ×10) μg/L.
BACKGROUND: Studies have indicated that use of an age-adjusted D-dimer cut-off value for patients above 50 years increases utility of the diagnostic strategy for pulmonary embolism. Evidence for the same approach regarding diagnosis of deep vein thrombosis (DVT) is, however, unclear. MATERIALS AND METHODS: A systematic literature review was conducted following the PRISMA Statement guideline to gather the existing knowledge on the use of an age-adjusted D-dimer cut-off in the diagnostic strategy for DVT. Studies were extracted from Medline and the Cochrane Library. The search period ended in November 2016. RESULTS: Out of 73 articles retrieved, only eight studies addressed DVT either specifically or along with PE. None of these were randomized controlled trials, but were either prospective studies of consecutive outpatients or retrospective studies. Despite differences in study design, DVT prevalence, and D-dimer assay used, all studies were in favour of the age-adjusted D-dimer cut-off with negative predictive values (NPV) ranging from 91.8-100% compared to 89.7-100% for the standard D-dimer cut-off. All the studies concluded that use of an age-adjusted D-dimer cut-off resulted in an improved utility, although the results due to heterogeneity in reporting did not allow a direct comparison. CONCLUSION: Use of an age-adjusted D-dimer cut-off for patients above 50 years of age for ruling out DVT seems as safe as using a standard D-dimer cut-off. The recommended (and most used) adjustment is by the formula (patient's age ×10) μg/L.
Entities:
Keywords:
Age-adjusted; D-dimer; deep vein thrombosis; literature review
Authors: Ana Cristina Lopes Albricker; Cláudia Maria Vilas Freire; Simone Nascimento Dos Santos; Monica Luiza de Alcantara; Mohamed Hassan Saleh; Armando Luis Cantisano; José Aldo Ribeiro Teodoro; Carmen Lucia Lascasas Porto; Salomon Israel do Amaral; Orlando Carlos Gloria Veloso; Ana Cláudia Gomes Pereira Petisco; Fanilda Souto Barros; Márcio Vinícius Lins de Barros; Adriano José de Souza; Marcone Lima Sobreira; Robson Barbosa de Miranda; Domingos de Moraes; Carlos Gustavo Yuji Verrastro; Alexandre Dias Mançano; Ronaldo de Souza Leão Lima; Valdair Francisco Muglia; Cristina Sebastião Matushita; Rafael Willain Lopes; Artur Martins Novaes Coutinho; Diego Bromfman Pianta; Alair Augusto Sarmet Moreira Damas Dos Santos; Bruno de Lima Naves; Marcelo Luiz Campos Vieira; Carlos Eduardo Rochitte Journal: Arq Bras Cardiol Date: 2022-04 Impact factor: 2.000
Authors: Thomas Ackmann; Burkhard Möllenbeck; Georg Gosheger; Jan Schwarze; Tom Schmidt-Braekling; Kristian Nikolaus Schneider; Adrien Frommer; Ralf Dieckmann; Christoph Theil Journal: J Clin Med Date: 2020-09-10 Impact factor: 4.241